Staphylococcus aureus

June 22, 2016June 22, 2016

Vibativ Potent Against Difficult-to-Treat Bacteria, Including MRSA

News

The drug Vibativ could be effective against hard-to-treat bacteria, according to a study presented at the American Society of Microbiology (ASM) Microbe 2016 Conference, June 16 – 20, in Boston. Developed ... Read more

May 13, 2016May 13, 2016

Theravance Poster to Show Phase 3 ATTAIN Trial Results on Pneumonia at ATS 2016

News, Pneumonia

Theravance Biopharma, Inc. recently announced in a press release the presentation of new data on VIBATIV® (telavancin), the company’s FDA-approved antibiotic, at the American Thoracic Society (ATS) 2016 International Conference, May 13-18 in San Francisco. The ... Read more

February 1, 2016February 3, 2016

E-cigarette Vapor Appears to Impair Immune System, Enhances Virulence of Airway Bacteria

Lung Cancer, News

Electronic or e-cigarettes impair innate immune defenses and promote the growth of bacteria in the airways, according to the results of a recent mouse study, “Electronic cigarette inhalation alters innate immunity ... Read more

October 22, 2015October 28, 2015

Protein Complex Found To Control MRSA Virulence; Could Impact Pneumonia, CF Treatments

News, Pneumonia

A new study revealed that human adherens junctions — a type of protein complex — control the virulence of Methicillin-resistant Staphylococcus aureus, also known as MRSA. The study entitled “The adherens ... Read more

September 29, 2015November 5, 2015

Researchers Find No Particular Resistance to Antibiotics in Young Cystic Fibrosis Patients Infected By Non-pseudomonal Bacterial Species

Cystic Fibrosis, News

In a recently published paper in PeerJ journal entitled “Comparative genomics of non-pseudomonal bacterial species colonizing young cystic fibrosis patients,” researchers from Australia analyzed a series of non-pseudomonal strain isolates ... Read more

July 24, 2015July 24, 2015

Theravance Biopharma’s VIBATIV Approved in Canada for Treatment of Adults With Ventilator-associated Bacterial Pneumonia

News, Pneumonia

Recently, Health Canada announced the approval of VIBATIV® (telavancin), from Theravance Biopharma, for treatment of adult individuals with hospital- (HAP) and ventilator-associated (VAP) bacterial pneumonia. It has been described that bacterial pneumonia ... Read more

June 22, 2015November 5, 2015

Staphylococcus Aureus Infection in CF Adult Patients Found To Be a Mild Disease Marker

Cystic Fibrosis, News

In a new study entitled “Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients,” the authors determined the prevalence of Staphylococcus aureus infection in ... Read more